| Mr Albert Okine, PA-C, MSPAS | |
|
3549 Southern Hills Dr, Sioux City, IA 51106-4736 | |
| (712) 274-6729 | |
| (712) 274-6744 |
| Full Name | Mr Albert Okine |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 18 Years |
| Location | 3549 Southern Hills Dr, Sioux City, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962558957 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 001776 (Iowa) | Secondary |
| 363A00000X | Physician Assistant | 001776 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Medical Services | 5799694063 | 116 |
| Rodney J Dean Md, Pc | 8628060654 | 7 |
News Archive
We live in a world of wireless signals flowing around us and bouncing off our bodies.
Adimab, LLC, a technology leader in the discovery of fully human antibodies, today announced the initiation of two independent collaborations with Biogen Idec and Novo Nordisk. Over the past two years, Adimab has established collaborations with multiple leading pharmaceutical companies, including: Merck, Roche, Novartis, Pfizer, Eli Lilly, Genentech, Human Genome Sciences, and now Biogen Idec and Novo Nordisk.
Early treatment response is a powerful predictor of long-term outcome for young patients with acute myeloid leukemia (AML). The information can help physicians decide whether a more intensive approach is needed. Research led by St. Jude Children's Research Hospital investigators has identified the best test for measuring that response and guiding therapy.
New research reveals that consuming two or more cups of coffee each day reduces the risk of death from liver cirrhosis by 66%, specifically cirrhosis caused by non-viral hepatitis. Findings in Hepatology, a journal published by Wiley on behalf of the American Association for the Study of Liver Diseases, show that tea, fruit juice, and soft drink consumption are not linked to cirrhosis mortality risk. As with previous studies heavy alcohol use was found to increase risk of death from cirrhosis.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Albert Okine, PA-C, MSPAS 3549 Southern Hills Dr, Sioux City, IA 51106-4736 Ph: (712) 274-6729 | Mr Albert Okine, PA-C, MSPAS 3549 Southern Hills Dr, Sioux City, IA 51106-4736 Ph: (712) 274-6729 |
News Archive
We live in a world of wireless signals flowing around us and bouncing off our bodies.
Adimab, LLC, a technology leader in the discovery of fully human antibodies, today announced the initiation of two independent collaborations with Biogen Idec and Novo Nordisk. Over the past two years, Adimab has established collaborations with multiple leading pharmaceutical companies, including: Merck, Roche, Novartis, Pfizer, Eli Lilly, Genentech, Human Genome Sciences, and now Biogen Idec and Novo Nordisk.
Early treatment response is a powerful predictor of long-term outcome for young patients with acute myeloid leukemia (AML). The information can help physicians decide whether a more intensive approach is needed. Research led by St. Jude Children's Research Hospital investigators has identified the best test for measuring that response and guiding therapy.
New research reveals that consuming two or more cups of coffee each day reduces the risk of death from liver cirrhosis by 66%, specifically cirrhosis caused by non-viral hepatitis. Findings in Hepatology, a journal published by Wiley on behalf of the American Association for the Study of Liver Diseases, show that tea, fruit juice, and soft drink consumption are not linked to cirrhosis mortality risk. As with previous studies heavy alcohol use was found to increase risk of death from cirrhosis.
› Verified 8 days ago